Dec. 23 at 3:29 PM
🚨
$PETV is emerging as a leader in regenerative veterinary therapeutics!
Record Q2 revenue up 51% year-over-year, with gross margin at 72.6% and liabilities down 79%
CATALYSTS TO WATCH
✅ Adoption ramp for RediVet therapies across U.S. veterinary networks
✅ Growth of http://PetVivo.ai platform + new digital distribution channels
✅ Earnings (Feb 2026 est.), potential updates on revenue traction & product rollout
CONTINUATION IDEA
Watching for continuation if price reclaims
$1.20
🎯-
$1.42,
$1.50,
$1.65
Communicated Disclaimer – https://chartingdaily.com/pet-joint-care
$CHWY $PETS